共 50 条
- [31] Treatment of adult patients with moderate-to-severe atopic dermatitis with dupilumab in early-phase clinical studies shows significant improvement in skin disease activity and pruritus: a review of study dataBRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (06) : E14 - E14Simpson, E.Beck, L.Thaci, D.Ardeleanu, M.Hamilton, J.Ren, H.Graham, N.Radin, A.
- [32] A PHASE 1/2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF THE INDUCTION OF CLINICAL RESPONSE AND REMISSION BY QBECO IN SUBJECTS WITH MODERATE TO SEVERE CROHN'S DISEASEGASTROENTEROLOGY, 2017, 152 (05) : S600 - S600Gunn, HalSutcliffe, SimonPankovich, JimChen, Jenny M.Vandermeirsch, GillianThompson, DarbyFedorak, Richard N.Panaccione, RemoAxler, Jeffrey L.Bressler, Brian
- [33] Comparative efficacy of a two-compound ointment containing calcipotriol 50ig/G and betamethasone 0.5 μg/g (As dipropionate) after 1, 2, and 4 weeks of treatment of mild, moderate, and severe psoriasisEADV: PROCEEDINGS OF THE 15TH CONGRESS OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, : 715 - +Menter, A.Ganslandt, C.
- [34] Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a StudyINFLAMMATORY BOWEL DISEASES, 2015, 21 (08) : 1809 - 1816Melmed, Gil Y.Pandak, William M.Casey, KevinAbraham, BincyValentine, JohnSchwartz, DavidAwais, DahliaBassan, IssacLichtiger, SimonSands, BruceHanauer, StephenRichards, RobertOikonomou, IoannisParekh, NimishaTargan, StephenJohnson, KristineHariri, RobertFischkoff, Steven
- [35] Association between clinical activity score and serum sPD-1 and sPD-L1 levels during systemic glucocorticoid treatment for active moderate-to-severe thyroid eye diseaseCYTOKINE, 2025, 187Cieplinska, KatarzynaNiedziela, EmiliaRdzanek, Agata KopaczSluszniak, AnnaChrapek, MagdalenaPalyga, IwonaKowalska, Aldona
- [36] Impact of Crohn's disease and treatment with certolizumab pegol 400 mg every 4 weeks on patient-reported health status: Data from PRECiSE 2AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S404 - S404Feagan, Brian G.Keininger, Dorothy L.Coteur, GeoffroySchreiber, Stefan
- [37] Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn's disease: interim analysis from the Phase 2 FITZROY studyJOURNAL OF CROHNS & COLITIS, 2016, 10 : S15 - S17Vermeire, S.Schreiber, S.Petryka, R.Kuehbacher, T.Hebuterne, X.Roblin, X.Klopocka, M.Goldis, E.Wisniewska-Jarosinska, M.Baranovsky, A.Sike, R.Tasset, C.Van der Aa, A.Harrison, P.
- [38] Human Placenta-Derived Cells (PDA001) for the Treatment of Moderate-to-Severe Crohn's Disease: Results of a Phase 1b/2a StudyAMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S636 - S636Melmed, GilPandak, WilliamCasey, KevinAbraham, BincyValentine, JohnSchwartz, DavidAwais, DahlliaLichtiger, SimonBassan, IsaacHanauer, StephenRichards, RobertOilonomou, IoannisParekh, NimishaTargan, StephanJohnson, KristineHariri, RobertFischkoff, Steven
- [39] Clinical and immunologic characteristics of European patients randomized for NORTHERN LIGHTS phase 2b study that assessed MC2-03 (ciclosporin 0.03% and 0.06%) for the treatment of moderate-to-severe dry eye diseaseINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)Gomez, FredericSelmer, JohanPrastegaard, MortenHeegaard, Steffen
- [40] Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trialLANCET, 2017, 389 (10066): : 266 - 275Vermeire, SeverineSchreiber, StefanPetryka, RobertKuehbacher, TanjaHebuterne, XavierRoblin, XavierKlopocka, MariaGoldis, AdrianWisniewska-Jarosinska, MariaBaranovsky, AndreySike, RobertStoyanova, KremenaTasset, ChantalVan der Aa, AnnegretHarrison, Pille